Moderna
MRNA
#797
Rank
A$37.87 B
Marketcap
$98.53
Share price
-3.43%
Change (1 day)
-38.91%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$37.87 Billion

As of September 2024 Moderna has a market cap of A$37.87 Billion. This makes Moderna the world's 797th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Market cap Change
2024A$37.87 B-31.95%
2023A$55.65 B-45.11%
2022A$101.40 B-28.4%
2021A$141.62 B163.98%
2020A$53.64 B472.91%
2019A$9.36 B31.44%
2018A$7.12 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Moderna was reported to be:

A$37.87 Billion
by Yahoo Finance info icon info icon
A$37.87 Billion
by CompaniesMarketCap info icon info icon
A$37.87 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
A$0.17 B-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
A$445.46 B 1,076.21%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.24 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
A$52.73 B 39.25%๐Ÿ‡บ๐Ÿ‡ธ USA
A$352.59 B 830.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$3.87 B-89.76%๐Ÿ‡บ๐Ÿ‡ธ USA
A$592.71 B 1,464.98%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.46 B-88.21%๐Ÿ‡บ๐Ÿ‡ธ USA